Study identifies molecule critical to asthma-causing cell’s survival
Scientists led by molecular immunologists at the Keck School of Medicine of the University of Southern California (USC) have identified a way to target a recently discovered cell type that causes asthma, paving the way to cure the chronic respiratory disease that affects 25 million Americans.
The team, which includes investigators from Janssen Research and Development, Dana-Farber Cancer Institute and Harvard Medical School, will publish its results in the March 17 edition of the peer-reviewed scientific journal Immunity.
Asthma is a chronic lung disease that irritates and narrows the airways, according to the Centers for Disease Control and Prevention. With no known cure for the 7 million children who suffer from this disease in the United States, as well as millions of adults, the goal of asthma treatment is to control the symptoms. The exact causes of this chronic disease are unknown, but researchers believe a combination of genetic and environmental factors contribute to developing asthma. Discovered within the last decade, type 2 innate lymphoid cells, or ILC2s, are a subset of immune cells that trigger primary asthma symptoms such as mucus production and hypersensitive airways. ILC2s do not express previously identified immune cell markers, however, making them tough to target.
“If we can target ILC2s, we might be able to cure asthma or exacerbations caused by these particular cells,” said Omid Akbari, Ph.D., associate professor of molecular and cellular immunology at the Keck School of Medicine of USC and principal investigator of the study.
Read more:Â Keck School of Medicine of USC scientists open door for asthma cure
The Latest on: Asthma Cure
[google_news title=”” keyword=”Asthma Cure” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Asthma Cure
- I Have Chronic Allergies — and the Cure Is Almost As Bad As the Symptomson April 26, 2024 at 9:15 pm
TikTok star, Lauren Ramos, details her life with chronic allergies, including having to carry an epi-pen just to get allergy shots.
- Intrinsic Vs Extrinsic Asthma: Expert Explains Symptoms, Causes, Diagnosis, And Treatmenton April 25, 2024 at 10:32 pm
Intrinsic and extrinsic asthma are subtypes of asthma that share similar symptoms but differ in their triggers age of onset and prevalence ...
- COPD and Asthma Devices Market From Insights to Strategy Unleashing the Power of Focus Group Dataon April 25, 2024 at 9:27 pm
COPD and Asthma Devices Market is valued approximately at USD 36.9 billion in 2019 and is anticipated to grow with a growth rate of more than 4.3% over the forecast period 2020-2027. Chronic ...
- FDA approves asthma drug for treating food allergieson April 25, 2024 at 1:03 pm
A drug newly approved by the Food and Drug Administration to reduce the risk of allergic reactions from food could bring relief to millions across the nation.
- Signs and Symptoms of an Asthma Attackon April 25, 2024 at 12:00 pm
An asthma attack can cause mild to severe symptoms. Coughing, wheezing, change in breathing patterns, and difficulty breathing are some common symptoms.
- Complacency Leading To Thousands Of U.K. Asthma Deaths, Charity Sayson April 24, 2024 at 9:01 pm
documented asthma treatment plans and inhaler technique checks. But even today, almost 70% of people surveyed by Asthma + Lung UK aren’t getting this basic care package. And few receive appropriate ...
- Mother's asthma plea after daughter's sudden deathon April 24, 2024 at 2:55 pm
The mother of a schoolgirl who died after an asthma attack has said sufferers should have regular checks to avoid "preventable" deaths like her daughter. Tracy Bulpitt's daughter Katy was 12-years-old ...
- World Asthma Day 2024 Webinar: How embracing FeNO Testing can Transform Asthma Careon April 24, 2024 at 4:11 am
Carol Stonham MBE to discuss how FeNO Testing can empower and educate healthcare professionals and patients. Image Credit: Bedfont Scientific Ltd.
- Novartis accused of promoting asthma drug for preterm labor despite brain riskon April 23, 2024 at 10:24 am
Novartis has been hit with a lawsuit by people with autism and their mothers alleging the drugmaker illegally promoted an asthma drug for treatment of preterm labor despite knowing it was ineffective ...
- Higher zinc intake linked to lower asthma risk in overweight kidson April 23, 2024 at 12:04 am
A study in the World Allergy Organization Journal reveals that higher dietary zinc intake is linked to a lower risk of asthma in overweight or obese children and adolescents, indicating zinc's ...
via Bing News